Jorgina Vila, MD, PhD

Vall d'Hebron Barcelona Hospital Campus, Spain

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1186) Significant Reduction in Disease Burden and a Shift in Clinical Diagnoses in Children Hospitalized with Respiratory Syncytial Virus (RSV) after Nirsevimab Implementation in Catalonia (Spain)
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT